ZBIO - Company ID 0001953926
The table below shows Zenas BioPharma, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|
| Cash & equivalents | $500.22M | $115.56M | $44.01M | $196.55M | $360.04M |
| Short-term investments | $216.98M | $175.32M | $229.27M | $115.83M | $26.76M |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $730.16M | $296.64M | $278.60M | $317.81M | $393.78M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment | $28.00K | $50.00K | $61.00K | $72.00K | $146.00K |
| Goodwill | - | - | - | - | - |
| Total assets | $747.68M | $322.02M | $293.08M | $333.77M | $403.43M |
| Accounts payable | $8.94M | $6.44M | $7.93M | $20.02M | $15.08M |
| Total current liabilities | $61.16M | $52.42M | $53.24M | $49.13M | $44.00M |
| Long-term debt | - | $72.99M | - | - | - |
| Total liabilities | $411.85M | $125.59M | $53.46M | $49.45M | $44.00M |
| Retained earnings | -$846.12M | -$524.69M | -$473.19M | -$420.96M | -$334.79M |
| Total equity | $335.83M | $196.43M | $239.63M | $284.32M | $359.44M |